Loading…
Axsome Therapeutics, Inc. is projected to rise to $300.01 by 2027, a +28% move from its current price of $233.80. AXSM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $229.37 | $234.00 | $238.73 | +0.09% |
| Jul 14 | $227.67 | $234.21 | $240.93 | +0.17% |
| Jul 15 | $226.43 | $234.41 | $242.68 | +0.26% |
| Jul 16 | $225.41 | $234.62 | $244.20 | +0.35% |
| Jul 17 | $224.55 | $234.82 | $245.57 | +0.44% |
| Jul 18 | $223.79 | $235.03 | $246.83 | +0.53% |
| Jul 19 | $223.10 | $235.23 | $248.02 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $223.10 | $235.23 | $248.02 | +0.61% |
| Week 2 | $219.60 | $236.67 | $255.07 | +1.23% |
| Week 3 | $217.26 | $238.13 | $260.99 | +1.85% |
| Week 4 | $215.52 | $239.59 | $266.34 | +2.47% |
| Week 5 | $214.14 | $241.05 | $271.35 | +3.10% |
| Week 6 | $213.04 | $242.53 | $276.11 | +3.73% |
| Week 7 | $212.13 | $244.02 | $280.70 | +4.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing and delivering novel therapies for central nervous system (CNS) disorders in the United States. Its commercial product portfolio includes Auvelity (dextromethorphan-bupropion), Sunosi (solriamfetol), and Symbravo (MoSEIC meloxicam rizatriptan), or AXS-07, indicated for the acute treatment of migraine, among other programs.
It also develops AXS-05 (dextromethorphan-bupropion) and other assets, with collaboration activities such as a Duke University research agreement evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Axsome Therapeutics, Inc. trades under the ticker AXSM and has a current price of $233.80 with a market cap of $12.03B, ranking 824. The near-term outlook indicates neutrality for 2026, with a bullish path emerging in subsequent years. The year-by-year forecast shows a clear upward trajectory through 2030 and well beyond.
A major floor 34.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.0% below — buyers have tended to step in here.
The nearest ceiling, 9.1% above — a clean break opens room to run.
A major ceiling 15.5% above — clearing it would confirm fresh momentum.
Key AXSM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AXSM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $244.14 | Sell | $242.25 | Sell |
| MA 10 | $243.32 | Sell | $243.18 | Sell |
| MA 20 | $245.76 | Sell | $242.32 | Sell |
| MA 50 | $234.47 | Sell | $230.65 | Buy |
| MA 100 | $202.65 | Buy | $211.20 | Buy |
| MA 200 | $176.66 | Buy | $184.79 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.22 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -154.41 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -1.52 | Sell |
| ROC (12) | -3.38 | Sell |
| Bollinger %B (20,2) | -0.00 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 3.03 | Buy |
| Ultimate (7,14,28) | 38.09 | Neutral |
| Momentum (10) | -3.53 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 244.97 | Sell |
| ADX (14) | 20.92 | Sell |
| ATR (14) | 4.33 | Info |
The 30-day technical picture remains cautiously bullish overall. The RSI(14) is 40, with the SMA50 at $234.47 and the SMA200 at $176.66, suggesting upside potential above the short-term average. Key levels to watch are support at $222.16 and resistance at $255.17.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $154.12 | $233.80 | $321.64 | 0% | Neutral | |
| $244.76 | $300.01 | $385.17 | +28% | Bullish | |
| $283.57 | $354.55 | $468.19 | +52% | Bullish | |
| $345.69 | $439.36 | $593.19 | +88% | Bullish | |
| $390.83 | $503.89 | $693.22 | +116% | Bullish | |
| $494.84 | $646.34 | $903.97 | +176% | Bullish | |
| $599.03 | $791.88 | $1,124.09 | +239% | Bullish | |
| $627.85 | $839.36 | $1,207.69 | +259% | Bullish | |
| $695.63 | $939.88 | $1,369.28 | +302% | Bullish | |
| $753.78 | $1,028.80 | $1,516.33 | +340% | Bullish | |
| $1,333.03 | $1,903.64 | $2,946.81 | +714% | Bullish | |
| $2,578.23 | $3,970.85 | $6,609.39 | +16.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $154.12 | $233.80 | $283.40 | +0.00% |
| August 2026 | $213.51 | $250.24 | $299.88 | +7.03% |
| September 2026 | $214.92 | $253.17 | $305.90 | +1.17% |
| October 2026 | $212.91 | $251.90 | $306.47 | -0.50% |
| November 2026 | $216.29 | $256.85 | $314.32 | +1.97% |
| December 2026 | $219.40 | $261.42 | $321.64 | +1.78% |
Click any year to see its month-by-month AXSM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AXSM to range from $154.12 to $321.64 through 2026. The $233.80 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AXSM price prediction for 2027 points to an average of $300.01 (low $244.76, high $385.17) — a potential gain of +28% on today's $233.80. Buyers look set to stay in control over this stretch.
In 2028, AXSM is projected to trade between $283.57 and $468.19, averaging $354.55 — a potential gain of +52% from today's $233.80. That is up +18% on the projected 2027 average. Momentum favours further upside here.
Axsome Therapeutics, Inc.'s 2029 outlook centres on $439.36, within a $345.69 to $593.19 range. That is up +24% on the projected 2028 average. That marks a +88% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, AXSM could reach as high as $693.22, with a base case around $503.89 and support toward $390.83 — roughly +116% from $233.80. Momentum favours further upside here.
Expect AXSM to range from $494.84 to $903.97 through 2031. The $646.34 average target implies a +176% move from current prices. That is up +28% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The AXSM price prediction for 2032 points to an average of $791.88 (low $599.03, high $1,124.09) — a potential gain of +239% on today's $233.80. Momentum favours further upside here.
In 2033, AXSM is projected to trade between $627.85 and $1,207.69, averaging $839.36 — a potential gain of +259% from today's $233.80. That is up +6% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Axsome Therapeutics, Inc.'s 2034 outlook centres on $939.88, within a $695.63 to $1,369.28 range. That is up +12% on the projected 2033 average. That marks a +302% change versus current levels. Momentum favours further upside here.
By 2035, AXSM could reach as high as $1,516.33, with a base case around $1,028.80 and support toward $753.78 — roughly +340% from $233.80. Buyers look set to stay in control over this stretch.
Expect AXSM to range from $1,333.03 to $2,946.81 through 2040. The $1,903.64 average target implies a +714% move from current prices. That is up +85% on the projected 2035 average. Momentum favours further upside here.
The AXSM price prediction for 2050 points to an average of $3,970.85 (low $2,578.23, high $6,609.39) — a potential gain of +16.0x on today's $233.80. Buyers look set to stay in control over this stretch.
Investing $1,000 in AXSM today (≈ 4.27716 AXSM) could be worth
$16,983.94
+$15,983.94 (+1598%) by 2050 · US Dollar
Based on the average projected AXSM price of $3,970.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AXSMwould be worth at today's price.
$1,000 invested in AXSM on Jul 10, 2025 (≈ 9.030976 AXSM) would be worth
$2,111.44
+$1,111.44 (+111.1%) today · 2.11× · US Dollar
Based on a AXSM entry price of $110.73 vs. today's $233.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $244.31 | $956.98 | -4.3% |
| 1 month ago | $246.34 | $949.09 | -5.1% |
| 3 months ago | $178.11 | $1,312.67 | +31.3% |
| 6 months ago | $176.82 | $1,322.25 | +32.2% |
| 1 year ago | $110.73 | $2,111.44 | +111.1% |
| All time (5.0y) ago | $63.42 | $3,686.53 | +268.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AXSM forecast.
Our base-case forecast reaches $470.00 around 2030.
Implied market cap at $470.00: $24.19B
Across the multi-year forecast, the expectation is for continued upside with rising average prices and sizable upside in later years. 2026 shows an average of $233.80 (neutral), then 2027 at $300.01 (ROI 28.3%), 2028 at $354.55 (ROI 51.6%), and 2029 at $439.36 (ROI 87.9%). By 2030 the average is $503.89 (ROI 115.5%), and 2035 reaches $1,028.80 (ROI 340), with a max outlook of $1,516.33.
The path continues to 2040 with an average of $1,903.64 (ROI 714.2%) and a 2050 average of $3,970.85 (ROI 1598.4%), all labeled bullish. These figures imply substantial upside over the long term, but they are estimates and not guarantees, and risks can vary with market conditions and execution milestones.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $503.89 with a min of $390.83 and a max of $693.22, and a projected ROI of 115.5% with a bullish sentiment.
The forecast turns bullish after 2026, with rising averages from 2030 onward (e.g., avg $503.89 in 2030, $1,903.64 in 2040, and $3,970.85 in 2050) and double- to triple-digit ROIs in later years, indicating strong upside potential but also noting the estimates are not guarantees.
Yes. The 2035 forecast shows an average price of $1,028.80 with a min of $753.78 and a max of $1,516.33, and a projected ROI of 340%.
For 2040, the forecast lists a min of $1,333.03, an average of $1,903.64, and a max of $2,946.81, with a ROI of 714.2% and a bullish sentiment.
The current price is $233.80 and the market cap is $12.03B, with a rank of 824.
Axsome Therapeutics, Inc. Community Discussion
0Share your Axsome Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.